vs
NATIONAL FUEL GAS CO（NFG）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
NATIONAL FUEL GAS CO的季度营收约是Orthofix Medical Inc.的1.9倍（$425.9M vs $219.9M），NATIONAL FUEL GAS CO净利率更高（35.7% vs -1.0%，领先36.7%），Orthofix Medical Inc.同比增速更快（2.0% vs 1.7%），过去两年NATIONAL FUEL GAS CO的营收复合增速更高（12.1% vs 8.0%）
该多元化能源企业成立于1902年，总部位于美国纽约州威廉斯维尔，总资产达62亿美元，下设勘探与生产、管道与存储、燃气集输、公用事业、能源营销五大运营板块，业务覆盖能源产业链上下游多个核心环节。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
NFG vs OFIX — 直观对比
营收规模更大
NFG
是对方的1.9倍
$219.9M
营收增速更快
OFIX
高出0.2%
1.7%
净利率更高
NFG
高出36.7%
-1.0%
两年增速更快
NFG
近两年复合增速
8.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $425.9M | $219.9M |
| 净利润 | $152.0M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 81.5% | 0.2% |
| 净利率 | 35.7% | -1.0% |
| 营收同比 | 1.7% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $1.59 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NFGOFIX
| Q1 26 | $425.9M | — | ||
| Q4 25 | $637.9M | $219.9M | ||
| Q3 25 | $443.1M | $205.6M | ||
| Q2 25 | $527.4M | $203.1M | ||
| Q1 25 | $734.8M | $193.6M | ||
| Q4 24 | $513.8M | $215.7M | ||
| Q3 24 | $310.0M | $196.6M | ||
| Q2 24 | $338.6M | $198.6M |
净利润NFGOFIX
| Q1 26 | $152.0M | — | ||
| Q4 25 | $181.6M | $-2.2M | ||
| Q3 25 | $107.3M | $-22.8M | ||
| Q2 25 | $149.8M | $-14.1M | ||
| Q1 25 | $216.4M | $-53.1M | ||
| Q4 24 | $45.0M | $-29.1M | ||
| Q3 24 | $-167.6M | $-27.4M | ||
| Q2 24 | $-54.2M | $-33.4M |
毛利率NFGOFIX
| Q1 26 | — | — | ||
| Q4 25 | 86.6% | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | 94.7% | 68.7% | ||
| Q1 25 | 81.6% | 62.8% | ||
| Q4 24 | 87.3% | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | 98.5% | 67.8% |
营业利润率NFGOFIX
| Q1 26 | 81.5% | — | ||
| Q4 25 | 43.3% | 0.2% | ||
| Q3 25 | 40.6% | -8.3% | ||
| Q2 25 | 43.7% | -7.9% | ||
| Q1 25 | 43.2% | -25.2% | ||
| Q4 24 | 16.8% | -5.3% | ||
| Q3 24 | -63.4% | -9.6% | ||
| Q2 24 | -15.2% | -12.5% |
净利率NFGOFIX
| Q1 26 | 35.7% | — | ||
| Q4 25 | 28.5% | -1.0% | ||
| Q3 25 | 24.2% | -11.1% | ||
| Q2 25 | 28.4% | -6.9% | ||
| Q1 25 | 29.4% | -27.4% | ||
| Q4 24 | 8.8% | -13.5% | ||
| Q3 24 | -54.1% | -13.9% | ||
| Q2 24 | -16.0% | -16.8% |
每股收益（稀释后）NFGOFIX
| Q1 26 | $1.59 | — | ||
| Q4 25 | $1.98 | $-0.05 | ||
| Q3 25 | $1.18 | $-0.57 | ||
| Q2 25 | $1.64 | $-0.36 | ||
| Q1 25 | $2.37 | $-1.35 | ||
| Q4 24 | $0.49 | $-0.76 | ||
| Q3 24 | $-1.81 | $-0.71 | ||
| Q2 24 | $-0.59 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | $300.0M | — |
| 股东权益账面价值 | — | $450.0M |
| 总资产 | $9.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NFGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $271.4M | $82.0M | ||
| Q3 25 | $43.2M | $62.9M | ||
| Q2 25 | $39.3M | $65.6M | ||
| Q1 25 | $40.0M | $58.0M | ||
| Q4 24 | $48.7M | $83.2M | ||
| Q3 24 | $38.2M | $30.1M | ||
| Q2 24 | $81.4M | $26.4M |
总债务NFGOFIX
| Q1 26 | $300.0M | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | $157.2M | ||
| Q2 25 | $2.7B | $157.0M | ||
| Q1 25 | $2.7B | $156.9M | ||
| Q4 24 | $2.7B | $157.0M | ||
| Q3 24 | $2.7B | $118.5M | ||
| Q2 24 | $2.7B | $118.0M |
股东权益NFGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $3.6B | $450.0M | ||
| Q3 25 | $3.1B | $442.5M | ||
| Q2 25 | $3.0B | $458.3M | ||
| Q1 25 | $2.8B | $458.3M | ||
| Q4 24 | $-76.2M | $503.1M | ||
| Q3 24 | $-15.5M | $525.9M | ||
| Q2 24 | $5.0M | $546.0M |
总资产NFGOFIX
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.2B | $850.6M | ||
| Q3 25 | $8.7B | $832.6M | ||
| Q2 25 | $8.4B | $837.2M | ||
| Q1 25 | $8.5B | $823.1M | ||
| Q4 24 | $8.3B | $893.3M | ||
| Q3 24 | $8.3B | $867.9M | ||
| Q2 24 | $8.5B | $882.0M |
负债/权益比NFGOFIX
| Q1 26 | — | — | ||
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.87× | 0.36× | ||
| Q2 25 | 0.90× | 0.34× | ||
| Q1 25 | 0.99× | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | 532.10× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $657.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | 117.0% | 4.9% |
| 现金转化率经营现金流/净利润 | 4.32× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流NFGOFIX
| Q1 26 | $657.3M | — | ||
| Q4 25 | $274.9M | $27.7M | ||
| Q3 25 | $237.8M | $12.4M | ||
| Q2 25 | $388.4M | $11.6M | ||
| Q1 25 | $253.8M | $-18.4M | ||
| Q4 24 | $220.1M | $23.7M | ||
| Q3 24 | $197.9M | $11.7M | ||
| Q2 24 | $281.8M | $9.0M |
自由现金流NFGOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-2.7M | $16.8M | ||
| Q3 25 | $-47.8M | $2.5M | ||
| Q2 25 | $195.3M | $4.5M | ||
| Q1 25 | $59.9M | $-25.1M | ||
| Q4 24 | $-20.3M | $15.2M | ||
| Q3 24 | $-49.1M | $6.3M | ||
| Q2 24 | $79.5M | $-360.0K |
自由现金流率NFGOFIX
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | 7.6% | ||
| Q3 25 | -10.8% | 1.2% | ||
| Q2 25 | 37.0% | 2.2% | ||
| Q1 25 | 8.2% | -13.0% | ||
| Q4 24 | -4.0% | 7.0% | ||
| Q3 24 | -15.8% | 3.2% | ||
| Q2 24 | 23.5% | -0.2% |
资本支出强度NFGOFIX
| Q1 26 | 117.0% | — | ||
| Q4 25 | 43.5% | 4.9% | ||
| Q3 25 | 64.4% | 4.8% | ||
| Q2 25 | 36.6% | 3.5% | ||
| Q1 25 | 26.4% | 3.5% | ||
| Q4 24 | 46.8% | 4.0% | ||
| Q3 24 | 79.7% | 2.7% | ||
| Q2 24 | 59.7% | 4.7% |
现金转化率NFGOFIX
| Q1 26 | 4.32× | — | ||
| Q4 25 | 1.51× | — | ||
| Q3 25 | 2.21× | — | ||
| Q2 25 | 2.59× | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 4.89× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NFG
| Revenues from External Customers | $425.8M | 100% |
| Intersegment Revenues | $126.0K | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
